111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-23.83%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-41.87%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-97.12%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-98.37%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-112.82%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-114.56%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-114.71%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.25%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.02%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
5.91%
Dividend growth above 1.5x MLM's 2.42%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-124.14%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-172.97%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
15.40%
10Y revenue/share CAGR under 50% of MLM's 116.61%. Michael Burry would suspect a lasting competitive disadvantage.
15.40%
5Y revenue/share CAGR under 50% of MLM's 44.45%. Michael Burry would suspect a significant competitive gap or product weakness.
15.40%
3Y revenue/share CAGR 1.25-1.5x MLM's 12.64%. Bruce Berkowitz might see better product or regional expansions than the competitor.
-7.82%
Negative 10Y OCF/share CAGR while MLM stands at 587.48%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-7.82%
Negative 5Y OCF/share CAGR while MLM is at 109.01%. Joel Greenblatt would question the firm’s operational model or cost structure.
-7.82%
Negative 3Y OCF/share CAGR while MLM stands at 31.47%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-268.56%
Negative 10Y net income/share CAGR while MLM is at 2599.22%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-268.56%
Negative 5Y net income/share CAGR while MLM is 358.17%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-268.56%
Negative 3Y CAGR while MLM is 455.41%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
12.03%
Below 50% of MLM's 131.49%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
12.03%
Below 50% of MLM's 75.38%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
12.03%
Below 50% of MLM's 44.73%. Michael Burry suspects a serious short-term disadvantage in building book value.
-64.08%
Cut dividends over 10 years while MLM stands at 91.29%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-64.08%
Negative 5Y dividend/share CAGR while MLM stands at 44.04%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-64.08%
Negative near-term dividend growth while MLM invests at 29.07%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
6.66%
AR growth well above MLM's 8.11%. Michael Burry fears inflated revenue or higher default risk in the near future.
4.31%
Inventory growth well above MLM's 5.20%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.58%
Positive asset growth while MLM is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-1.91%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
11.01%
Debt growth far above MLM's 0.05%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-5.17%
We cut SG&A while MLM invests at 21.50%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.